Navigation Links
BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
Date:2/1/2011

rome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA, PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU, BMN 701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical development for the treatment of Pompe disease, and BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, which is currently in Phase I/II clinical development for the treatment of genetically-defined cancers. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking StatementThis press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the development of its program for MPS IVA, and particularly the timing and conduct of clinical trials related thereto, expectations regarding other clinical and preclinical programs, and the potential market for GALNS, if approved. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: the results of current and planned pre-clinical trials related to BioMarin's development programs and particularly the enzyme replacement therapy for MPS IVA; the content and timing of decisions by the U.S. Food and Drug Administration, EMEA and other regulatory agencies, particularly with respect to the enzyme replacement therapy for MPS IVA, the actual number of MPS IVA patients in the developed world; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, includi
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. BioMarin Announces FDA Approval for Kuvan
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- "Fatty Liver Disease Global Clinical Trials Review, H2, ... trial scenario. This report provides elemental information and data ... Disease . It includes an overview of the trial ... of trial conduction across the globe. The databook offers ... phase, trial status, prominence of the sponsors and also ...
(Date:8/27/2014)... WARSAW, Ind. , Aug. 27, 2014  Zimmer ... in musculoskeletal care, announced that it will be participating ... the Grand Hyatt in New York, New ... David Dvorak , President and CEO of Zimmer, will ... Binder , President and CEO of Biomet, will join ...
(Date:8/27/2014)... , NEW YORK and LONDON ... provider of market research solutions, MarketResearch.com is pleased ... its Kalorama Information Medical Devices Knowledge Center. ... easy-to-use platform hosting the latest market research in ... entire library of reports from industry expert, Kalorama ...
Breaking Medicine Technology:Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 2Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 3Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 4Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 5MarketResearch.com: New Medical Devices Research Reports Added to Kalorama Information Knowledge Center 2MarketResearch.com: New Medical Devices Research Reports Added to Kalorama Information Knowledge Center 3
... SEATTLE, May 2, 2011 CMC Biologics, a ... Copenhagen, Denmark and Seattle, Washington USA, announced today ... at its Chief Executive Officer. CMC Biologics, a ... world class, fully integrated, biopharmaceutical process development and ...
... SAN DIEGO, May 2, 2011 Volcano Corporation (NASDAQ: ... of precision intravascular diagnosis and therapy guidance tools designed ... disease, said today that it will be participating in ... May 10. The presentation by John Dahldorf, ...
Cached Medicine Technology:CMC Biologics Announces Appointment of New CEO 2
(Date:8/27/2014)... Jaha was founded with a vision that fitness is ... industry’s most affordable fitness tracker together with an app to ... Jaha plans to announce their latest concept, an ... locate, challenge and motivate. , The Jaha Kickstarter ... support and to raise awareness on this new concept for ...
(Date:8/27/2014)... August 27, 2014 Nava Beauty Store and ... to all patrons from those seeking luxury care products to ... They carry high end luxurious brands like Valmont and Elemis ... also sells brands like Dermalogica and Bliss to provide easy ... customers. They also offer purely organic skin care products such ...
(Date:8/27/2014)... Many patients believe mental illness is ... has a mortality rate of about 15%. The ... less, though it's offset by an alarming homicide rate ... to properly treat and manage symptoms of mental illnesses ... taken as directed. Missed dosages or cutting pills ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Sugar ... climatic conditions and fluctuations in global supply and demand, ... past five years. The industry derives a large share ... subject to global market dynamics, with supply and prices ... and India. A strong Australian dollar for the majority ...
(Date:8/27/2014)... Mass., (PRWEB) August 27, 2014 BCC ... ADVANCED ORTHOPEDIC TECHNOLOGIES, IMPLANTS AND REGENERATIVE PRODUCTS , ... to increase from $36.4 billion by 2014-end to $42.2 ... (CAGR) of 3% from 2014 to 2019. New technologies ... major driving forces within the market. , While there ...
Breaking Medicine News(10 mins):Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2Health News:Nava Beauty Store Announce Grand Opening in Great Neck, New York 2Health News:MedicationDiscountCard.com now Makes Brintellix and Mental Illness Medications More Affordable with Discount Cards 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3
... themselves and their partners, organizers say , FRIDAY, June ... of HIV testing is among the goals of the ... To mark the day, thousands of HIV testing sites, ... fairs, provide community and media outreach, host special testing-related ...
... Trends, News and Insights to Eye Care Practitioners Nationwide , ... & Lomb announces the launch of the Center for Patient ... to unbiased industry information, trends, market research, and insights for ... Patient Insights, main goal is to deliver news and insights ...
... CVS Caremark (NYSE: CVS ) is proud ... nation,s leading corporations for innovative programs promoting a healthy workplace and ... about their own health and well-being. , , ... , CVS Caremark received the Best Employers for Healthy Lifestyles ...
... Get ... Centers for Disease Control and Prevention (CDC) estimates that one out of five people living with ... is an opportunity for people nationwide to gain knowledge to take control of their health and ... Ft. Myers, FL (PRWEB) ...
... ... the nation,s third largest nationally recognized physician multi-specialty certifying organization , has formed ... ... American Board of Physician Specialties (ABPS) today announced the formation of the American Board ...
... 25 Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... request of the Food and Drug Administration, today arrived ... The seizure also included ingredients held at these same ... facility, completed in May 2009, found unresolved violations of ...
Cached Medicine News:Health News:Bausch & Lomb Announces New Center for Patient Insights 2Health News:CVS Caremark Recognized with Gold Award from National Business Group on Health for Promoting Healthy Lifestyles for Employees 2Health News:CVS Caremark Recognized with Gold Award from National Business Group on Health for Promoting Healthy Lifestyles for Employees 3Health News:JustGetTested.com Offers Fast, Confidential HIV Testing to Mark National HIV Testing Day 2Health News:American Board of Family Medicine Obstetrics Formed 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action 2
... The new line of Myoquick systemplus Multi-channels Evoked ... of Micromed in the neurophysiology field and shows ... Multi-channel EP unit adopt the 32 channels headbox ... of the ISA 100x EP family headboxes: ISA ...
Solid steel construction for lifelong quality. Strong, smooth and quiet electro-mechanical up/down movement. Dual castor, locking wheels for use on carpet or tile flooring. Easy cleaning, deluxe lami...
If you presently have an exam chair that is separate from the instrument stand, we can solve your access problem with a Burton 1200 Chair-exchanger...
... A marvel of engineering and innovative ... precision, unparalleled quality and masterful workmanship. At ... bring the ophthalmic industry a truly innovative ... From product design to quality construction and ...
Medicine Products: